Claudia A. Seipp

25.3k total citations · 12 hit papers
49 papers, 19.8k citations indexed

About

Claudia A. Seipp is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claudia A. Seipp has authored 49 papers receiving a total of 19.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 24 papers in Immunology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claudia A. Seipp's work include Immunotherapy and Immune Responses (16 papers), Sarcoma Diagnosis and Treatment (13 papers) and CAR-T cell therapy research (11 papers). Claudia A. Seipp is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Sarcoma Diagnosis and Treatment (13 papers) and CAR-T cell therapy research (11 papers). Claudia A. Seipp collaborates with scholars based in United States, Malaysia and Australia. Claudia A. Seipp's co-authors include Steven A. Rosenberg, Donald E. White, Michael T. Lotze, Suzanne L. Topalian, Douglas J. Schwartzentruber, James Chih‐Hsin Yang, Colleen Simpson, Alfred E. Chang, Nicholas P. Restifo and Susan F. Leitman and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Claudia A. Seipp

49 papers receiving 19.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 2.2k citations Steven A. Rosenberg, Michael T. Lotze et al. profile →
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

2002 2.2k citations Mark E. Dudley, John R. Wunderlich et al. profile →
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

1985 2.0k citations Steven A. Rosenberg, Michael T. Lotze et al. profile →
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

1988 1.8k citations Steven A. Rosenberg, Paul Aebersold et al. profile →
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1998 1.5k citations Steven A. Rosenberg, James Chih‐Hsin Yang et al. Nature Medicine profile →
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

2003 1.2k citations Giao Q. Phan, James Chih‐Hsin Yang et al. Proceedings of the National Academy of Sciences profile →
The Treatment of Soft-tissue Sarcomas of the Extremities

1982 1.0k citations Steven A. Rosenberg, Joel E. Tepper et al. Annals of Surgery profile →
Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

1989 786 citations Steven A. Rosenberg, Michael T. Lotze et al. Annals of Surgery profile →
Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

1994 779 citations Steven A. Rosenberg, James Chih‐Hsin Yang et al. JNCI Journal of the National Cancer Institute profile →
Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer

2003 573 citations James Chih‐Hsin Yang, Richard M. Sherry et al. Journal of Clinical Oncology profile →
Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma

2002 565 citations John Toso, Vee J. Gill et al. Journal of Clinical Oncology profile →
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 488 citations Michael T. Lotze, Claudia A. Seipp et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Claudia A. Seipp

Since Specialization

Citations

This map shows the geographic impact of Claudia A. Seipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia A. Seipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia A. Seipp more than expected).

Fields of papers citing papers by Claudia A. Seipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia A. Seipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia A. Seipp. The network helps show where Claudia A. Seipp may publish in the future.

Co-authorship network of co-authors of Claudia A. Seipp

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia A. Seipp. A scholar is included among the top collaborators of Claudia A. Seipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia A. Seipp. Claudia A. Seipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma breakdown → 2003 ·Proceedings of the National Academy of Sciences ·Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, (unknown), Kathleen E. Morton, Sharon Mavroukakis, Paul H. Duray, Seth M. Steinberg, James P. Allison, Thomas A. Davis, Steven A. Rosenberg	1234
2	Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens 2003 ·Journal of Immunotherapy ·Giao Q. Phan, Christopher E. Touloukian, James C. Yang, Nicholas P. Restifo, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Claudia A. Seipp, (unknown), Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg	91
3	Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen 2003 ·Human Gene Therapy ·Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, (unknown), Kathleen E. Morton, Sharon Mavroukakis, Donald E. White	85
4	Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma breakdown → 2002 ·Journal of Clinical Oncology ·John Toso, Vee J. Gill, Patrick Hwu, Francesco M. Marincola, Nicholas P. Restifo, Douglas J. Schwartzentruber, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Frida Stock, (unknown), Kathleen E. Morton, Claudia A. Seipp, Leah Haworth, Sharon Mavroukakis, Donald White, Susan MacDonald, John Mao, Mario Sznol, Steven A. Rosenberg	565
5	Anal Verrucous Carcinoma and Penile Condylomata acuminata 2000 ·Dermatology ·Shi‐Long Lu, Walter Bodemer, Christiane Ostwald, M Barten, (unknown), Claudia A. Seipp, Gerd Gross	7
6	Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine 1999 ·The Journal of Immunology ·Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Patrick Hwu, Francesco M. Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Mario Sznol, Susan Schwarz, Paul J. Spiess, John R. Wunderlich, Claudia A. Seipp, Jan Einhorn, Linda Rogers-Freezer, Donald E. White	141
7	Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens 1998 ·JNCI Journal of the National Cancer Institute ·Steven A. Rosenberg, Yifan Zhai, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, (unknown), Franco Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Claudia A. Seipp, Jan Einhorn, Donald E. White, (unknown)	9
8	Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens 1998 ·JNCI Journal of the National Cancer Institute ·Steven A. Rosenberg, Yifan Zhai, (unknown), Douglas J. Schwartzentruber, (unknown), Francesco M. Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Claudia A. Seipp, Jan Einhorn, Donald E. White, Bruce Roberts	245
9	Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma breakdown → 1998 ·Nature Medicine ·Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Patrick Hwu, (unknown), Suzanne L. Topalian, Nicholas P. Restifo, Mark E. Dudley, Susan Schwarz, Paul J. Spiess, Maria R. Parkhurst, Yutaka Kawakami, Claudia A. Seipp, Jan Einhorn, Donald E. White	1480
10	The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma 1995 ·Cancer ·James C. Yang, Suzanne L. Topalian, Douglas J. Schwartzentruber, David Parkinson, (unknown), (unknown), Claudia A. Seipp, Donald E. White, Steven A. Rosenberg	64
11	The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma 1995 ·Cancer ·Mark Macfarlane, James Chih‐Hsin Yang, (unknown), Richard L. White, Claudia A. Seipp, Jan Einhorn, Donald E. White, Steven A. Rosenberg	38
12	Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer 1993 ·JNCI Journal of the National Cancer Institute ·S A Rosenberg, Michael T. Lotze, Jin‐Hao Yang, Suzanne L. Topalian, (unknown), Douglas J. Schwartzentruber, Paul Aebersold, S.F. Leitman, W. Marston Linehan, Claudia A. Seipp, (unknown), Seth M. Steinberg	452
13	Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients breakdown → 1989 ·Annals of Surgery ·Steven A. Rosenberg, Michael T. Lotze, James Chih‐Hsin Yang, Paul Aebersold, W. Marston Linehan, Claudia A. Seipp, Donald E. White	786
14	Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. 1988 ·Journal of Clinical Oncology ·Suzanne L. Topalian, D. Solomon, (unknown), Alfred E. Chang, (unknown), W. Marston Linehan, Michael T. Lotze, Cary N. Robertson, Claudia A. Seipp, Perikles Simon	356
15	Comparison of Median Sternotomy and Thoracotomy for Resection of Pulmonary Metastases in Patients with Adult Soft-Tissue Sarcomas 1986 ·The Annals of Thoracic Surgery ·Jack A. Roth, Harvey I. Pass, Margaret N. Wesley, Donald White, Joe B. Putnam, Claudia A. Seipp	132
16	High-grade soft tissue sarcomas of the extremities 1986 ·Cancer ·Dorothy A. Potter, Timothy J. Kinsella, Eli Glatstein, Robert Wesley, Donald E. White, Claudia A. Seipp, Alfred E. Chang, Ernest E. Lack, José Costa, Steven A. Rosenberg	233
17	Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. 1985 ·PubMed ·Jerry Glenn, (unknown), Timothy J. Kinsella, Eli Glatstein, Joel E. Tepper, Juliene Gonçalves Costa, A Baker, Paul H. Sugarbaker, Murray F. Brennan, Claudia A. Seipp	122
18	A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy 1981 ·Cancer ·David J. Shiling, R. C. Stillman, Alfred E. Chang, Nelson H. Goldberg, Claudia A. Seipp, Ivan Barofsky, Steven A. Rosenberg	73
19	Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), M. Wayne Flye, David M. Conkle, Claudia A. Seipp, AS Levine, Richard Simon	27
20	Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate 1979 ·Annals of Internal Medicine ·Alfred E. Chang, David J. Shiling, R. C. Stillman, Nelson H. Goldberg, Claudia A. Seipp, Ivan Barofsky, Richard Simon, Steven A. Rosenberg	204

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact